Skip to main content

NRX Pharmaceuticals, Inc.

NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001719406

No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in NRX Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
30
−2 vs. Q4 2022
Shares held
3.15M
+63.8K (+2.1%) vs. Q4 2022
Total value
$2.07M
−$1.35M (−39.4%) vs. Q4 2022
New holders
2
10 more added
Sold out
4
7 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 30 institutions
Q1 2021: 1 institutionQ2 2021: 18 institutionsQ3 2021: 23 institutionsQ4 2021: 38 institutionsQ1 2022: 34 institutionsQ2 2022: 37 institutionsQ3 2022: 30 institutionsQ4 2022: 33 institutionsQ1 2023: 30 institutionsQ2 2023: 32 institutionsQ3 2023: 34 institutionsQ4 2023: 30 institutionsQ1 2024: 31 institutionsQ2 2024: 19 institutionsQ3 2024: 18 institutionsQ4 2024: 25 institutionsQ1 2025: 22 institutionsQ2 2025: 25 institutionsQ3 2025: 24 institutionsQ4 2025: 28 institutionsQ1 2026: 33 institutionsQ2 2026: 47 institutions
Value heldQ1 2023: $2.07M
Q1 2021: $4.00KQ2 2021: $18.9MQ3 2021: $16.2MQ4 2021: $12.4MQ1 2022: $25.1MQ2 2022: $2.18MQ3 2022: $3.04MQ4 2022: $3.44MQ1 2023: $2.07MQ2 2023: $4.78MQ3 2023: $964.7KQ4 2023: $1.84MQ1 2024: $1.76MQ2 2024: $1.29MQ3 2024: $1.21MQ4 2024: $2.31MQ1 2025: $4.60MQ2 2025: $9.76MQ3 2025: $13.0MQ4 2025: $14.2MQ1 2026: $13.2MQ2 2026: $47.6M
Institutions holding NRXP and their total value by quarter
QuarterHoldersValue
Q2 202647$47.6M
Q1 202633$13.2M
Q4 202528$14.2M
Q3 202524$13.0M
Q2 202525$9.76M
Q1 202522$4.60M
Q4 202425$2.31M
Q3 202418$1.21M
Q2 202419$1.29M
Q1 202431$1.76M
Q4 202330$1.84M
Q3 202334$964.7K
Q2 202332$4.78M
Q1 202330$2.07M
Q4 202233$3.44M
Q3 202230$3.04M
Q2 202237$2.18M
Q1 202234$25.1M
Q4 202138$12.4M
Q3 202123$16.2M
Q2 202118$18.9M
Q1 20211$4.00K

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q4 2022.

Institutions holding NRXP in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc1,478,153$974.3K0.00%+34,990+2.4%Added
Geode Capital Management, LLC378,667$249.6K0.00%00.0%Unchanged
BlackRock Inc.375,247$247.3K0.00%+2,718+0.7%Added
Bridgeway Capital Management, LLC230,700$152.1K0.00%+52,000+29.1%Added
State Street Corp114,240$75.3K0.00%00.0%Unchanged
Susquehanna International Group, LLP80,623$53.1K0.00%+52,895+190.8%Added
Northern Trust Corp71,241$47.0K0.00%+12,643+21.6%Added
Texas Capital Bank Wealth Management Services Inc63,290$41.7K0.00%00.0%Unchanged
Morgan Stanley47,326$31.2K0.00%−3,012−6.0%Reduced
Virtu Financial LLC46,210$30.0K0.00%+46,210New
Charles Schwab Investment Management Inc43,732$28.8K0.00%00.0%Unchanged
Bank of America Corp30,000$19.8K0.00%−5,809−16.2%Reduced
HBK Sorce Advisory LLC29,230$19.3K0.00%−29,230−50.0%Reduced
Advisor Group Holdings, Inc.27,225$17.9K0.00%00.0%Unchanged
Renaissance Technologies LLC25,300$17.0K0.00%+7,700+43.8%Added
Group One Trading, L.P.21,326$14.1K0.00%−25,178−54.1%Reduced
UBS Group AG18,611$12.3K0.00%+18,221+4,672.1%Added
United Asset Strategies, Inc.18,300$12.1K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)14,842$10.0K0.00%+8,740+143.2%Added
Wolverine Asset Management LLC11,141$7.34K0.00%−4,686−29.6%Reduced
Bank of New York Mellon Corp10,129$6.68K0.00%00.0%Unchanged
Wells Fargo & Company5,309$3.50K0.00%+5+0.1%Added
Cutler Group LP3,220$2.00K0.00%00.0%Unchanged
GWM Advisors LLC2,125$1.40K0.00%+1,300+157.6%Added
Citadel Advisors LLC247$1630.00%−12,309−98.0%Reduced
Larson Financial Group LLC218$1440.00%00.0%Unchanged
Column Capital Advisors, LLC100$660.00%00.0%Unchanged
JPMorgan Chase & Co339$00.00%00.0%Unchanged
Royal Bank of Canada126$00.00%−2−1.6%Reduced
VitalStone Financial, LLC10$00.00%+10New
AE Wealth Management LLC0$00.00%−29,515−100.0%Sold out
Exchange Traded Concepts, LLC0$00.00%−26,924−100.0%Sold out
HRT Financial LP0$00.00%−26,501−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−10,453−100.0%Sold out
Jenkins Wealth––––Not filed